Dr. Brown joined Synthetic Genomics in 2007 to build and lead a multifunctional team in the design and development of microbes for the production of advanced biofuels. He now leads SGI’s world-class phototrophic strain development group. Dr. Brown has over 20 years of experience in molecular biology and gene expression in the biotechnology sector. Prior to SGI, he was a senior scientist Diversa Corp., developing recombinant expression systems for industrial enzymes and animal vaccines.
Earlier in his career, Dr. Brown served in senior research and science roles for Solexa Ltd. (acquired by Illumina), Dow Chemical, Chirotech Ltd. and Chiroscience Plc. Dr. Brown received his Ph.D. in Bacterial Pathogenesis from the Centre of Microbial Research and Microbiology, in the U.K. He has more than 20 issued patents and additional pending applications in various areas of industrial biotechnology.